A Study of Relative Bioavailability and Food Effect Study of Cobimetinib in Healthy Participants
Status:
Completed
Trial end date:
2011-01-10
Target enrollment:
Participant gender:
Summary
This study will be an open-label, randomized, 3-way, 6-sequence crossover study in healthy
participants for determining the relative bioavailability of the tablet formulation to the
capsule formulation and the effect of food on the relative bioavailability of the tablet
formulation.